Indefinite Delivery Contract SPE2DU25D9788
- Not listed
- The federal contract IDV award SPE2DR25D9133 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business, with the Defense Logistics Agency (DLA). The contract, valued at $4,999,999, covers the provision of a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities...
- The federal contract IDV award SPE2DR25D9934 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of...
- The federal contract IDV award SPE2DU25D9166 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award $499,999,999 Indefinite Delivery Contract (IDC) enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical...
- The federal contract IDV award SPE2DU25D9132 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract covers a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health...
- The federal contract IDV award SPE2DU25D9142 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables....
- The federal contract IDV award SPE2DR25D9207 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,999,999 single-award Indefinite Delivery Contract (IDC) enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply...
- The federal contract IDV award SPE2DR25D9151 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other federal agencies. This single-award Indefinite Delivery Contract (IDC), valued at up to $4,999,999, covers a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The federal contract IDV award with ID SPE2DU25D9524 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, provides the DLA with firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The federal contract IDV award SPE2DR25D9767 is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which is valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications,...
- The federal contract IDV award SPE2DU25D9770 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
The federal contract IDV award SPE2DU25D9788 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $4,999,999, covers the delivery of a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, a $30.3 billion unrestricted acquisition aimed at establishing multiple regional prime vendor contracts to provide pharmaceutical support to various DoD customers. DMS Pharmaceutical Group's contract enables the DLA to issue firm fixed-price delivery orders for a diverse portfolio of pharmaceutical items to Continental U.S. (CONUS) and Outside CONUS (OCONUS) locations, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala. The contract has a base period of 30 months and three 30-month option periods, expiring on December 31, 2036.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/7/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global GEN V Presolicitation | SPE2DX-24-R-0001 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/5 | 2/1/24, 3:44 PM | |
Pharmaceutical Prime Vendor Global GEN V Solicitation | SPE2DX-24-R-0001_SOLICITATION | Defense Logistics Agency Troop Support Medical | Solicitation 2/5 | 3/13/24, 11:08 AM | |
PPVG GEN V Award | SPE2DX-25-D-1000 | Defense Logistics Agency Troop Support Medical | Award Notice 3/5 | 3/7/25, 10:09 AM | |
PPVG GEN V AWARD SPE2DX25D9000 | SPE2DX25D9000 | Defense Logistics Agency Troop Support Medical | Award Notice 4/5 | 3/7/25, 10:14 AM | |
PPVG GEN V AWARD SPE2DX25D8000 | SPE2DX25D8000 | Defense Logistics Agency Troop Support Medical | Award Notice 5/5 | 3/7/25, 10:18 AM |